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Abstract 
There is a large body of clinical data documenting that most human carcinomas 
contain reduced levels of the catalytic subunit of the mitochondrial H+-ATP synthase. In 
colon and lung cancer this alteration correlates with a poor patient prognosis. 
Furthermore, recent findings in colon cancer cells indicate that down-regulation of the 
H+-ATP synthase is linked to the resistance of the cells to chemotherapy.  However, the 
mechanism by which the H+-ATP synthase participates in cancer progression is 
unknown. In this work, we show that inhibitors of the H+-ATP synthase delay 
staurosporine-induced cell death in liver cells that are dependent on oxidative 
phosphorylation for energy provision whereas it has no effect on glycolytic cells. 
Efficient execution of cell death requires the generation of reactive oxygen species 
(ROS) controlled by the activity of the H+-ATP synthase in a process that is concurrent 
with the rapid disorganization of the cellular mitochondrial network. The generation of 
ROS after staurosporine treatment is highly dependent on the mitochondrial membrane 
potential and most likely caused by reverse electron flow to Complex I. The generated 
ROS promote the carbonylation and covalent modification of cellular and mitochondrial 
proteins. Inhibition of the activity of the H+-ATP synthase blunted ROS production, 
prevented the oxidation of cellular proteins and the modification of mitochondrial 
proteins, delaying the release of cyt c and the execution of cell death. The results in this 
work establish the down-regulation of the H+-ATP synthase, and thus of oxidative 
phosphorylation, as part of the molecular strategy adapted by cancer cells to avoid 
reactive oxygen species-mediated cell death. Furthermore, the results provide a 
mechanistic explanation to understand chemotherapeutic resistance of cancer cells that 
rely on glycolysis as main energy provision pathway. 
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Introduction 
Mitochondria play a central role in the physiology of higher eukaryotic cells. 
Genetic and/or epigenetic alterations that impact on mitochondrial functions are thus 
involved in the development of a vast array of human pathologies (1). The provision of 
metabolic energy by oxidative phosphorylation (2) and the execution of cell death (3-6) 
are two cellular functions of mitochondria involved in the progression of human 
diseases. However, recent findings indicate the molecular and function integration of 
cellular metabolism with apoptosis (7-10). In this regard, the requirement of oxidative 
phosphorylation for efficient execution of cell death is a matter of debate. For instance, 
some authors have suggested that cells devoid of mtDNA (ρº), which are unable to carry 
on oxidative phosphorylation, undergo apoptosis as efficiently as their parental ρ+ cells 
(11-13) whereas other authors suggested the opposite, i.e., the ρº cells have a resistant 
apoptotic phenotype (14-16). Contributing to the same debate it has been reported that 
oligomycin, a specific inhibitor of the H+-ATP synthase, is a promoter (17,18) or an 
inhibitor (19,20) of apoptosis. In addition, the activity of oxidative phosphorylation has 
been shown to be required for Bax induced toxicity in yeast cells (21). Indeed, genetic 
screens in yeast, aimed at the identification of genes that could confer a Bax-resistance 
phenotype, allowed the identification of a subunit of the mitochondrial H+-ATP 
synthase critical for Bax-mediating killing of S. cerevisiae (19). Moreover, Bax-
mediated killing of the budding yeast has been shown to be strictly dependent upon 
select mitochondrial components such as the nuclear encoded β-subunit of the H+-ATP 
synthase and mitochondrial genome-encoded proteins (22). More recently, a specific 
repression of the expression of the β-subunit of the H+-ATP synthase has been 
documented in rat hepatocarcinomas (23) as well as in the tumor biopsies of liver, 
colon, kidney, lung, breast, gastric and esophageal cancer patients (24-26). These 
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findings have been recently confirmed (27-29) and extended to other carcinomas (30). 
Remarkably, the expression level of the β-subunit of the H+-ATP synthase in lung (26) 
and colon (24) cancer significantly correlated with the prognosis of the patients. 
Moreover, recent findings indicate that resistance to 5-fluorouracil treatment is linked to 
the down-regulation of the H+-ATP synthase in colon cancer cells (31). Reasoning that 
there are enough indications for the participation of the H+-ATP synthase in the 
execution of cell-death and in cancer progression, we undertook the following approach 
designed to characterize the mechanistic contribution of the mitochondrial H+-ATP 
synthase in staurosporine-triggered cell-death in liver cells. The results presented 
support that the activity of the H+-ATP synthase and thus, the dependence on oxidative 
phosphorylation for cellular ATP provision, defines the susceptibility of a cell to 
execute ROS-dependent cell death by the mitochondrial geared pathway.  
Materials and Methods 
Cell cultures and cell recovery. Rat liver clone 9 (C9) (32) and rat hepatoma 
AS30D and FAO cells (23) were grown as previously described. The C9 and FAO cells 
were recovered from the plates by trypsin treatment except for the analysis of caspase 3 
activities in which case were scrapped off in PBS. For all the assays AS30D cells were 
recovered by centrifugation. 
Mitochondrial membrane potential (∆Ψm) and mitochondrial mass. The 
fluorescent TMRM+ and NAO probes (Molecular Probes, Eugene, Oregon) were used 
to analyze ∆Ψm (33) and mitochondrial mass by flow cytometry, respectively. Different 
concentrations of FCCP (0-5 µM) were used to titrate ∆Ψm. The cellular fluorescence 
intensity was measured using a FACScan flow cytometer (Becton-Dickinson, San José, 
CA.). For each analysis 10,000 events were recorded.  
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Determination of caspase 3 activity. After various treatments the cells were 
harvested and lysed at 4ºC  in 5 mM Tris/HCl, pH 8.0, 20 mM EDTA, 0,5% Triton X-
100. For the determination of caspase 3 activities the fluorescent caspase 3 substrate Ac-
DEVD-AMC was used (34). Fluorescence was measured in a Microplate Fluorescence 
Reader FL600 Luminiscence Spectrophotometer (Perkin Elmer LS-50) (λexcitation, 380 
nm; λemission, 440 nm). Protein concentration in the cellular lysates was determined using 
the Bio-Rad protein assay kit.  
Protein electrophoresis and Western blot analysis. The cells were resuspended 
in a lysis buffer containing 25 mM Hepes, 2.5 mM EDTA, 0.1% Triton X-100, 1 mM 
PMSF and 5 µg/ml leupeptin. Cellular proteins were fractionated on SDS-12% PAGE 
and then transferred onto PVDF membranes (23). The primary monoclonal antibodies 
used were: anti-caspase 9 antibody (NeoMarkers, 1:1000), anti-GFP antibody 
(Clontech, 1:1000) and anti-α-tubulin antibody (Sigma, 1:1000). The primary 
polyclonal antibodies used were: anti-caspase 3 antibody (D157, Cell Signaling, 1:500), 
anti-Endo G antibody (ψProSci Incorporated, 2µg/ml), anti-AIF antibody (Oncogene, 
2.5µg/ml), anti-Bax antibody (Santa Cruz, 1:1000), anti-Bcl-XL antibody (Santa Cruz, 
1:1000) and anti-β-F1-ATPase antibody (24). Peroxidase-conjugated anti-mouse or anti-
rabbit IgGs (Nordic Immunology, 1:3000) were used as secondary antibodies. The blots 
were revealed using the ECL® reagent (Amersham Pharmacia Biotech, Little Chalfont, 
U.K.).  
Nuclear DNA staining. Control and treated C9 cells growing on coverslips were 
fixed with 4% paraformaldehyde in PBS and further permeabilized with methanol. Cell 
nuclei were stained using a 300 nM solution of 4,6-diamidino-2-phenylindole (DAPI, 
Sigma). Coverslips were observed in a Leica DMIRB fluorescence microscope 
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(λexcitation, 358 nm; λemission, 461 nm). The percentage of fragmented nuclei was counted 
in twenty different fields per condition assayed.  
Analysis of the cell cycle and nuclear DNA content by flow cytometry. The cells 
were treated as indicated, harvested and fixed in 70% ice-cold ethanol for at least 12 h 
at 4ºC. Afterwards, cells were treated with RNase (100 µg/ml) for 30 min at 37°C. The 
ploidy determination of the cells was estimated by flow cytometric analysis after 
staining of DNA with propidium iodide. The DNA content per cell was then evaluated 
in a FACScan. For computer analysis only the signals from single cells were considered 
(10,000 cells/assay). 
Determination of ATP. Approximately, 2 x 106 cells were precipitated and 
extracted with 100 µl of a 6 % perchloric acid solution. After centrifugation at 15,000 x 
g, to remove cell debris, the resulting supernatants were neutralized with 2 % KOH. The 
determination of the cellular concentration of ATP was carried out by standard 
enzymatic procedures.  
Determination of mitochondrial width. The distribution and morphology of 
mitochondria in cells exposed to different conditions was analyzed in C9 cells stably 
expressing a variant of gfp (32) that is localized in the matrix of the organelle 
(Martínez-Diez et al., to be described elsewhere) using a Leica DMIRB fluorescence 
microscope equipped with a GFP excitation filter (Leica, Switzerland; BP 470/40).The 
mitochondrial transversal section (width) is the most constant dimension of the 
organelle and variations on this parameter reflect an alteration of the morphology of 
mitochondria. The determination of the mitochondrial width was carried out in digital 
images acquired at 60x magnification with a Leica DC100 camera. For processing of 
digital images the Leica QWin software package was used (32). For every condition 
tested the width of 100-200 mitochondria in at least 100 different cells was determined. 
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Immunofluorescence / Confocal microscopy. Fluorescence and indirect 
immunofluorescence microscopy was performed on mitochondria-tagged gfp C9 cells 
after various treatments. Cells grown on coverslips were fixed with 4% 
paraformaldehyde in PBS. After, the coverslips were treated with a solution containing 
0.1% Triton X-100 in PBS for 10 minutes to permeabilize the cells. Coverslips were 
then blocked in a PBS solution containing 0.1% Triton X-100 and 1% fetal calf serum 
for 10 min. Coverslips were incubated with mouse monoclonal anti-cytochrome c 
antibody (PharMigen, 1:200). After three PBS rinses, the cells were incubated for 45 
min in the dark with a 1:1000 dilution of goat anti-rabbit or goat anti-mouse IgGs 
conjugated to Alexa 594. Nuclei were stained with the label ToPro3 (Molecular 
Probes). Cellular fluorescence was analyzed by confocal microscopy using a Biorad 
Radiance 2000 Zeiss Axiovert S100TV using the following excitation/emission wave 
lengths: green (498/516nm), red (590/617nm) and blue (642/661nm). In another set of 
experiments, C9 cells treated as indicated were incubated with 1µM acridine orange 
during 10 min at 37ºC. After, the cells were washed twice with PBS and the 
fluorescence emission of the probe analyzed in a Leica DMIRB fluorescence 
microscope. 
Determination of reactive oxygen species.  The analysis of intracellular H2O2 
production was performed using two different oxidation-sensitive probes, DCFH2-DA 
and C-2938 (Molecular Probes, Eugene, Oregon) and methodologies. For DCFH2-DA 
staining by fluorimetry we proceeded as described (34). For C-2938 staining, 
approximately 5x105 cells were resuspended in 300 µl of PBS and incubated 30 min at 
37ºC with 5 µM C-2938. Propidium iodide (1 µg/ml) was used to detect dead cells that 
were excluded from the analysis. Cells were analyzed in a FACScan. For each analysis 
10,000 events were recorded. 
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Detection of protein carbonylation. The Oxyblot Oxidized Protein Detection kit 
(Chemicon International) was used to detect protein oxidation of cellular proteins after 
various treatments. DNPH derivatization was carried out as indicated by the supplier on 
20 µg of cellular protein. Protein samples were fractionated on SDS-12% PAGE and 
processed for western blotting. The antibodies used were rabbit anti-DNPH  (1:150) and 
goat anti-rabbit IgGs (1:300). The blots were revealed using the ECL® reagent 
(Amersham Pharmacia Biotech, Little Chalfont, U.K.). 
Two-dimensional (2D) gel electrophoresis. Analytical 2-D gel electrophoresis 
was performed to fractionate mitochondria-tagged gfp C9 cellular proteins using the 
immobiline DryStrip Kit (Pharmacia-LKB). Briefly, gels were rehydrated in a solution 
containing 8 M urea, 0.5 % (v/v) Triton X-100, 1.3 mM dithiothreitol and 0.005 % (v/v) 
Pharmalyte 3-10. The first dimension separation (IEF) was performed in 110 x 3 mm 
polyacrylamide gels containing an immobilized pH 3-10 gradient, at 300 V for 1h and 
1,400 V for 17h at a constant temperature of 20º C. The second-dimension separation 
(SDS) was in 12.5 % polyacrylamide gels (14 x 13 cm) at room temperature overnight. 
Equal amounts of protein (175 µg) derived from freeze-dried cellular extracts were 
resuspended in the rehydration solution and applied to the strips. After electrophoresis, 
the gels were either stained or processed for Western blotting.  
Online supplementary material. For live imaging presented in the supplementary 
video, mitochondria-tagged gfp C9 cells were grown on glass plates and live images in 
a Cell Observer Zeiss equipment were taken using a Zeiss Axiovert 200 inverted 
microscope with a Coolsnap FX CCD camera (Roper Scientific). Images were taken 
every 3 min for 30 frames with a 40x objective and a gfp filter. The Metamorph 6.1r6 
(Universal Imaging) program was used for image processing.  
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Results  
The activity of the H+-ATP synthase is required for efficient execution of cell 
death in C9 liver cells. Consistent with previous findings (19,20,35) we observed that 
3h pre-incubation of C9 cells with oligomycin (OL) significantly delayed the cell death 
response to staurosporine (STS) as assessed both by the analysis of cell nuclei 
morphology (Fig. 1A) and intracellular DNA content (Fig. 1B). However, at 24h after 
STS treatment the rates of cell death were not significantly affected in the cells treated 
with OL (Fig. 1B). At short term, OL treatment was a stronger repressor of cell death 
than the caspase inhibitor z-Vad.fmk (Fig. 1A). To confirm the specific role of the H+-
ATP synthase in the execution of cell death aurovertin B, a different inhibitor of the 
mitochondrial enzyme, was used. The results obtained revealed essentially the same 
findings as those obtained with OL (Fig. 1C).  
Liver C9 cells treated with OL were arrested at the G0/G1 phase of the cell cycle 
(Fig. 1D) with significant reduction of cells in S phase and accumulation of cells at 
G0/G1 as treatment with the drug persisted (Fig. 1D). OL per se did not promote the 
induction of cell death in this cell line even after 12 h of treatment (Fig. 1B,D). 
Removal of OL from the culture medium allowed the re-establishment of cell 
proliferation (Fig. 1D). These results suggest that ATP produced by oxidative 
phosphorylation is required to enter into the S phase of the cell cycle.  Consistent with 
this finding, we observed that inhibition of the H+-ATP synthase by OL promoted a 
significant ~ 25 % reduction in the cellular concentration of ATP (Fig. 1E). However, 
the cellular concentration of ATP in OL treated cells was not significantly different 
from that of cells treated with STS or with the combination of both drugs (Fig. 1E). 
Inhibition of other cellular ATPases enhanced STS-induced cell death. To 
exclude possible side effects of OL on other cellular ATPases we studied its effect on 
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the subcellular compartmentalization and fluorescence emission of acridine orange. In 
normal cells, this fluorophore is trapped within acidic cellular granules (Fig. 2). OL did 
not affect the subcellular distribution and fluorescence emission of acridine orange in 
C9 cells (Fig. 2), suggesting the lack of effect of the inhibitor of the mitochondrial H+-
ATP synthase on the activity of other cellular ATPases. In contrast, bafilomycin B1, an 
inhibitor of cellular ATPases unrelated to the mitochondrial H+-ATP synthase (36), 
promoted the loss of the red emission signal of acridine orange as a result of the 
alkalization of the cellular granules triggered by the inhibition of the ATPases present in 
these organelles (Fig. 2). Moreover, and contrary to the results obtained with OL (Fig. 
1A,B), incubation of the cells with STS plus bafilomycin B1 promoted a high increase 
in cell death, to levels even higher than those obtained when the cells were incubated 
with STS alone (Fig. 2). These results suggest that prevention of cell death by OL is 
unrelated to side-effects of the inhibitor of the mitochondrial H+-ATP synthase on other 
cellular ATPases. 
Inhibition of H+-ATP synthase does not prevent the dismantling of mitochondrial 
reticulum after STS treatment. To visualize the possible effects of OL on mitochondrial 
morphology after STS treatment we used a stable C9 cell line expressing gfp in their 
mitochondria. Treatment of the cells with OL did not significantly affect the distribution 
and morphology of mitochondria in liver C9 cells (Fig. 3A). In contrast, STS treatment 
promoted the rapid (less than 10 min) dismantling of the cellular mitochondrial 
network, the migration of fragmented mitochondria towards the cell nucleus and the 
subsequent fusion of mitochondria into larger size organelles (see video 1 in 
supplementary material and Fig. 3A). Different time-frames of the movie illustrating the 
STS-mediated changes on the mitochondrial network are presented on Fig. 3B. 
However, the effects of STS on mitochondrial morphology were not prevented by 
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incubation of the cells with OL (Fig. 3A) or with the caspase inhibitor z-Vad.fmk (Fig. 
3A).  
Inhibition of H+-ATP synthase delays the release of cyt c from mitochondria.  
Determination of the mitochondrial membrane potential (∆Ψm) after priming the cells 
to death revealed an early (1h) increase in TMRM+ fluorescence in STS treated cells 
(Fig. 4A). Contrary to this finding, we observed no significant changes in NAO 
fluorescence after STS treatment of the cells (data not shown). The increase in TMRM+ 
fluorescence triggered by STS was obliterated in the presence of OL (Fig. 4A). 
Thereafter, ∆Ψm declined in both STS and STS+OL treated cells (Fig. 4A). It should be 
noted that using the pH sensitive BCECF-AM fluorescent probe we were unable to 
detect acidification of the cell cytoplasm in response to STS treatment during the early 
stage (first 3h) of cell death (data not shown).   
The release of cyt c from mitochondria-tagged gfp C9 liver cells was studied in 
response to treatment of the cells with STS and STS+OL (Fig 4B and 4C).  Fig 4B 
illustrates the STS-induced morphologic changes on mitochondria, the release of cyt c 
and the fragmentation of nuclear DNA in C9 cells treated with STS for three hours. 
Treatment of the cells with OL was unable to prevent the changes on mitochondrial 
morphology but prevented STS-induced nuclear DNA fragmentation (Fig. 4B, 1A and 
1B) and significantly affected the release of cyt c from mitochondria (Fig. 4B and 4C).  
In agreement with this last observation we noted that the activation of caspase 3 in 
response to STS treatment was significantly delayed in the presence of OL (Fig. 4D) 
although this effect was not significant at longer times of incubation (Fig. 4D). The 
mitochondrial release of cyt c was initiated after 90 min incubation of the cells with 
STS (Fig. 4C), a time when morphological changes on the mitochondrial network had 
already occurred (Fig. 3B and movie 1 in supplementary material). It should be noted 
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that inhibition of the MPT pore with CsA did not prevent the release of cyt c from 
mitochondria and the induction of cell death after STS treatment (data not shown).  
The H+-ATP synthase controls the production of ROS after STS treatment. STS 
treatment of liver cells promoted a rapid (maximum production at ∼ 90 min) and 
significant increase in the production of H2O2 as assessed by two different methods and 
fluorescent probes (Fig. 5A and 5B). Incubation of liver cells with rotenone, an inhibitor 
of Site I of the respiratory chain, blocked the STS-mediated increase in H2O2 production 
(Fig. 5A). Interestingly, OL also abolished the STS-mediated increase in ROS 
production (Fig. 5A and 5B). Consistent with a role for the generated ROS in signaling 
the execution of cell death we observed that STS-mediated cell death was also 
significantly reduced in rotenone-treated C9 cells (~ 50%, P<0.005, data not shown). 
Moreover, titration of ∆Ψm with increasing concentrations of FCCP indicated a dose-
dependent reduction of H2O2 production as ∆Ψm declines (Fig. 5C).  
Limiting ROS availability after STS treatment delays the release of cyt c from 
mitochondria and the execution of cell death. To establish a link between mitochondrial 
ROS production and the execution of cell death the effects of two antioxidants were 
studied. α-tocopherol is not able to quench mitochondrial ROS production and 
consistently it did not prevent ROS production and cell death triggered by STS (data not 
shown). In contrast, pyrrolidine dithiocarbamate (PDTC), a well characterized 
antioxidant in liver cells, partially quenched ROS production after STS treatment (Fig. 
5D) and blunted the STS-mediated cell death in C9 cells (Fig. 5E). Moreover, a 
significant delay in the release of cyt c was observed in PDTC-treated cells after STS 
treatment (Fig. 5F). Consistent with this finding, we observed that PDTC treatment 
arrested the STS-induced activation of caspase 3 (Fig. 5G).  
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The H+-ATP synthase controls the extent of oxidative modification of cellular 
proteins. One of the cellular targets of the toxic oxygen radicals is the covalent 
modification of proteins. Treatment of the cells with STS promoted a significant 
increase in the carbonylation of some cellular proteins (Fig. 6A). Remarkably, 
incubation of the cells with OL prevented the STS-triggered oxidation of the proteins 
(Fig. 6A). Likewise, the covalent modification of proteins could be tracked by changes 
in their pI, as revealed by fractionation of cellular proteins on 2D-gels. Analysis of AIF 
in liver C9 cells treated with STS revealed that a large fraction of the protein 
experienced a significant acidic shift in its pI when compared to non-treated C9 cells 
(Fig. 6B). Similar findings were obtained for Endo G (Fig. 6B). OL treatment prevented 
the STS-mediated shift in the pI of AIF and Endo G (Fig. 6B). It should be noted that 
the covalent modification of mitochondrial proteins after STS treatment is non-selective 
because it also affected the ectopically expressed gfp, an effect that was also partially 
prevented by OL (note the tailing in pI of the acidic form of gfp in Fig. 6B). However, 
and in the specific case of gfp, OL per se also affected the pI of the expressed protein 
(see the basic gfp form in Fig. 6B), suggesting the participation of additional factors in 
the modification of this protein. 
The cellular dependence on oxidative phosphorylation determines the 
contribution of the H+-ATP synthase to the execution of cell death. We next studied the 
contribution of the mitochondrial H+-ATP synthase in the cell death response to STS in 
two hepatoma cell lines, FAO and AS30D that differ substantially in their energetic 
phenotype ((23) and see references therein). The FAO hepatoma has a differentiated 
phenotype qualitatively resembling that of the normal hepatocyte whereas the AS30D 
hepatoma has a poorly differentiated phenotype.  Incubation of AS30D cells with OL 
did not affect the cellular concentration of ATP (Fig. 7A), a finding that is consistent 
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with the lack of dependence on oxidative phosphorylation for energy provision in this 
highly glycolytic cell line. Likewise, STS or the combination of STS+OL treatment to 
AS30D cells, did not affect the cellular concentration of ATP (Fig. 7A).  Analysis of 
cell death response to STS treatment in AS30D cells revealed that this hepatoma is 
highly resistant to the death stimulus because we observed no increase in the number of 
dying cells after six hour treatment with the drug (data not shown). In agreement with 
the negligible contribution of the bioenergetic function of mitochondria to cellular 
energy provision in AS30D cells (Fig. 7A), we observed no differences in ROS 
production after treatment of the cells with STS or with STS plus OL (Fig. 7B).   
In contrast, incubation of FAO cells with OL promoted a significant three-fold 
decrease in the cellular content of ATP (Fig. 7C), strongly suggesting that these cells 
largely depend on oxidative phosphorylation for cellular ATP provision. STS treatment 
also reduced the cellular ATP levels of FAO cells although not at a lesser extent than 
OL (Fig. 7C). Contrary to the findings in AS30D cells, treatment of FAO cells with STS 
triggered the activation of cell death (Fig. 7D). In agreement with the results found in 
C9 cells (Fig. 1A and 4D), the caspase inhibitor z-Vad.fmk abrogated caspase 3 
activation in FAO cells (Fig. 7D) although it could only reduce partially the extent of 
cell death (Fig. 7D). In addition, OL was as effective as z-Vad.fmk in preventing cell 
death in these cells (Fig. 7D), indicating a relevant role for the H+-ATP synthase in the 
execution of cell death in FAO cells. STS treatment of FAO cells also promoted a rapid 
(maximum production at ∼ 30 min) and significant increase in H2O2 production (Fig. 
7E).  It should be noted that both the relative cellular production and time scale of H2O2 
production after STS treatment were much more intense and rapid in FAO than in C9 
cells (compare Fig. 7E versus 5A and 5B for FAO and C9, respectively). Incubation of 
FAO cells with rotenone also blocked STS-mediated increase in H2O2 production 
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(P<0.05, data not shown). Consistent with the role of the H+-ATP synthase in 
controlling the generation of ROS after STS treatment we found that OL significantly 
reduced H2O2 production in STS-treated FAO cells (Fig. 7E). However, whereas in C9 
cells OL completely blocked ROS production (Fig. 5A and 5B), it was only able to 
reduce ROS production in FAO cells (Fig. 7E), suggesting the existence of alternative 
pathways of ROS generation in this cell line.  
Finally, to exclude the possibility that STS could also trigger cell death of the 
cell lines analyzed in this study (C9, FAO and AS30D) through the extrinsic pathway 
we analyzed the expression of Bid and tBid in response to STS treatment. The results 
(Fig. 7F) revealed an absence of Bid expression in C9 cells or of Bid processing in FAO 
and AS30D cells, suggesting that the cell death response to STS treatment in the C9 and 
FAO cells is primarily executed via the mitochondrial pathway. In addition, the relative 
cellular expression of Bax and Bcl-XL were analyzed in C9, FAO and AS30D cells 
(Bcl-2 is not expressed in these cell lines). The results showed that the apoptotic 
potential of these cells, as assessed by the ratio of the pro-apoptotic Bax to the anti-
apoptotic Bcl-XL, was four and eight fold higher in C9 cells than in FAO and AS30D 
cells, respectively (Fig. 7F). 
 
Discussion 
Cells can engage in several programmed cell death (PCD) pathways in response 
to a death stimulus (6). In this study we have analyzed the cell death response to STS in 
liver cells that have a differential dependence on oxidative phosphorylation for cellular 
energy provision. The results indicate that the cell death response to STS differs 
significantly depending upon the relative activity of the mitochondrial pathway for the 
provision of metabolic energy. It appears that the H+-ATP synthase is a key component 
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of PCD because its activity is involved in the generation of ROS, a death signal that is 
generated in the early induction phase of PCD that is required for efficient execution of 
cell death (6,37,38). The generated ROS are further responsible for the oxidation and 
covalent modification of mitochondrial constituents facilitating in this way the release 
of apoptogenic molecules from the mitochondria that will effectively swamp the cells 
into death. Within this scenario, the cell death response triggered by STS in STS-
sensitive liver cells has features of PCD executed both by apoptosis and caspase-
independent cell death pathways, being the activity of the H+-ATP synthase required in 
both pathways. It is unlikely that necrosis, triggered by ATP depletion of the cell, plays 
a role in STS-induced cell death in FAO and C9 cells. In fact, OL treatment induced a 
reduction in cellular ATP concentrations even larger (FAO cells) or at least similar (C9 
cells) to that observed in STS-treated cells. However, in both cell lines OL treatment 
prevented cell death. These results are in agreement with a similar recent observation in 
MOLT-3 cells (39).  
Molecular constituents that are involved in the regulation of the morphology of 
mitochondria play an important role in controlling the execution of cell death (40-42), 
although it appears that the contribution of such changes during apoptosis could depend 
on the nature of the death-inducing signal (43). A very early event after STS treatment 
is the dismantling of the cellular mitochondrial reticulum into punctiform organelles. 
We show here that OL is unable to prevent the alteration of the cellular mitochondrial 
reticulum after STS treatment. However, OL effectively delays the release of cyt c and 
the execution of cell death in response to STS, suggesting that the dismantling of the 
mitochondrial network is not sufficient to commit the cells to death and that the H+-ATP 
synthase participates in the regulation of PCD downstream this event.  
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As previously shown by others (35,44), we observed that STS promoted an early 
increase in TMRM+ retention in the mitochondria consistent with an increase in ∆Ψm 
brought about by the inhibition of cellular respiration (45). Increased TMRM+ retention 
may be due to a true increase in ∆Ψm or to the apparent increase in mitochondrial 
volume that occurs early after STS-addition (see Fig. 3A). The findings that NAO 
fluorescence did not reveal significant changes after STS treatment (data not shown) 
and that OL+STS treatment to the cells caused similar changes on mitochondrial 
morphology to that of STS alone (see Fig. 3A) but abrogated the increase in TMRM+ 
retention (see Fig. 4A) indicate a true increase in ∆Ψm after STS treatment. It has been 
described that upon inhibition of mitochondrial respiration ATP generated by glycolysis 
supports ∆Ψm (35,46-48). In this situation, the H+-ATP synthase is forced to hydrolyze 
ATP generating matrix ADP3- that would be exchanged with cytosolic ATP4- generated 
by glycolysis. The electrogenic exchange of the nucleotides by adenine nucleotide 
translocase and the ATP-supported proton pumping activity of the ATPase are both 
likely to contribute to the maintenance of a high ∆Ψm in the early phase after STS 
treatment (35,46-48). In fact, inhibition of the ATPase activity with OL prevented ∆Ψm 
hyperpolarization after STS treatment. It is well established that ROS production by 
mitochondria is highly dependent on the proton motive force (49,50). We have observed 
that ROS production after STS treatment was dose-dependently inhibited by titration of 
∆Ψm with the uncoupler FCCP. Furthermore, ROS production after STS treatment was 
abolished in the presence of the inhibitor rotenone, consistent with ROS being produced 
in this situation due to reverse transport of electrons from Complex II-linked respiratory 
substrates into Complex I ((50,51) and references therein). Consistently, inhibition of 
the ATPase-supported high ∆Ψm with OL suppressed ROS production. 
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 Our results suggest that the ATPase-supported high ∆Ψm induced by STS and 
the subsequent generation of ROS precede the release of cyt c from mitochondria. In 
fact, blocking the increase in ∆Ψm by OL treatment prevented ROS generation, 
attenuated cyt c release and the activation of caspase 3, delaying the execution of PCD. 
Likewise, quenching of the generated ROS by PDTC treatment attenuated cyt c release 
and the execution of cell death, although we cannot exclude that PDTC might have 
additional effects on caspases (52) because caspase 3 activation and DNA fragmentation 
are completely blocked with this treatment. These findings support that the generated 
ROS are not an epiphenomenon of PCD but rather a required signal (53) for the 
efficient execution of cell death in oxidative phosphorylation-dependent (FAO and C9) 
cells. It has been suggested that reverse functioning of the H+-ATP synthase contributes 
to cytoplasm acidification, as determined by changes in the fluorescence emission of a 
mitochondrial targeted pH-sensitive gfp probe (35). In our case, we were unable to 
detect significant acidification of the cytoplasm at early stages of PCD after STS 
treatment (data not shown). However, we did observe that mitochondrial-targeted gfp 
suffers ROS-mediated covalent modifications in response to STS treatment what might 
have affected the fluorescence spectrum of the pH-sensitive probe used in that study 
(35). 
ROS are known to promote oxidative damage of cellular constituents (DNA, 
lipids and proteins) as well as alterations in the signal transduction pathways that 
control the expression of genes required to execute cell death (52,54). More recently, 
the diminished production of ROS observed in the non-cleavable p75 mutant of 
Complex I has also been associated with the maintenance of plasma membrane integrity 
and the externalization of phosphatidylserine (55). Consistent with a role for ROS in 
PCD, we illustrate here that the generated ROS after STS treatment promote the 
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carbonylation of cellular proteins as well as covalent modifications of mitochondrial 
proteins. Remarkably, these modifications are prevented by inhibition of ROS 
production with OL, strongly supporting the role of the activity of the H+-ATP synthase 
in controlling the extent of oxidative modification of mitochondrial constituents. 
Although the results in this study illustrate the rapid ROS-mediated covalent 
modification of AIF and Endo G, they do not necessarily imply that such changes are 
required for the cell death activity of these molecules. In fact, the apoptotic activity of 
AIF has been shown to be independent of such changes (56). Rather, we speculate that 
the extent of non-specific ROS-mediated modifications of mitochondrial constituents 
(illustrated on the ectopically expressed gfp) could represent a critical point of 
regulation of the mitochondria-geared PCD pathway because it could define the 
threshold value of irreversible damage of the mitochondria and the set-point for the 
release of the mitochondrial arsenal that controls PCD.   
Interestingly, our results indicate that the cell death response to STS differs 
significantly depending upon the relative contribution of mitochondrial oxidative 
phosphorylation to the provision of metabolic energy in the cell. In this regard, FAO, 
C9 and AS30D cells could respectively represent liver cell types that rely highly-, 
medium- and none on mitochondrial oxidative phosphorylation for cellular energy 
provision as assessed by the effect of OL on their respective cellular ATP 
concentrations. While the FAO and C9 cells display a phenotype sensitive to the drug, 
the AS30D cells are resistant to the cell death stimulus. Consistently, the inhibition of 
the H+-ATP synthase activity by OL attenuated the execution of apoptosis in FAO and 
C9 cells. Overall, these findings are in agreement with previous reports that described 
the importance of an efficient oxidative phosphorylation for the execution of apoptosis 
(14-16,21,35) and with the role of the H+-ATP synthase in apoptotic cell death 
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(19,20,22). Furthermore, our data suggest that the controversial findings in the literature 
regarding the requirement or not of oxidative phosphorylation for efficient execution of 
apoptosis could arise as a result of bioenergetic differences of the cellular types that 
have been studied. Nonetheless, it should be noted that the cell death response to STS 
could also be modulated by additional cellular factors. In this regard, the higher 
Bax/Bcl-XL ratio found in C9 than in FAO cells might contribute to the higher total 
apoptosis observed in C9 cells after STS treatment.  
The generation of ROS is a physiological process that depends on the cellular 
activity of mitochondrial respiration, determining the life span of cells and organisms 
(57). On the other hand, and perhaps unexpectedly, glycolysis, the alternative energy 
producing pathway of the cell, is also integrated with apoptosis (7-9). In this regard, we 
suggest that cells that rely heavily on glycolysis for energy production, such as the 
AS30D hepatoma, display an apoptotic resistant phenotype similar to ρº cells (14-16) 
because ROS signaling after chemotherapeutic targeting of the mitochondria is blunted. 
In contrast, cells that depend on oxidative phosphorylation for ATP provision 
experience PCD via ROS signaling. Therefore, it is not surprising that the expression of 
the H+-ATP synthase, and perhaps of other OXPHOS complexes, is down-regulated in 
most human tumors while the expression of some glycolytic markers shows just the 
opposite trend (24-26). This situation provides the cancer cell with an advantageous 
bioenergetic phenotype because the potential for ROS production is diminished, 
oxidative damage to cellular constituents would be reduced, and the threshold for PCD 
induction will be higher, whilst glycolytic metabolism could support the energetic 
demand that allows cellular proliferation and tumor expansion.  
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Abbreviations: ROS, reactive oxygen species; cyt c, cytochrome c; AIF, apoptosis 
inducing factor; Endo G, endonuclease G; mtDNA, mitochondrial DNA; PBS, 
phosphate buffered saline; ∆Ψm, mitochondrial membrane potential; TMRM, 
tetramethyl rhodamine methyl ester; EDTA, ethylenediaminetetraacetic acid; PMSF, 
phenyl methyl sulfonyl fluoride; PAGE, polyacrylamide gel electrophoresis; SDS, 
sodium dodecyl sulfate; PVDF, Polyvinylidene fluoride; GFP, green fluorescent 
protein; ECL, luminol electrochemiluminescence; DAPI, 4,6-diamidino-2-phenylindole; 
Ac-DEVD-AMC, acetyl-Asp-Glu-Val-Asp-7-amino-4-methyl; DTT, dithiothreitol; 
DCFH2-DA,2´,7´-dichlorodihydrofluorescein diacetate; DNPH, dinitrophenylhydrazine; 
C-2938, 6-carboxy-2',7'-dichlorodihydrofluorescein diacetate di(acetoxymethyl ester); 
PDTC, pyrrolidine dithiocarbamate; pI, isoelectric point; Drp1, dynamin-related protein 
1; MPT, mitochondrial permeability transition; FCCP, carbonyl cyanide p-
trifluoromethoxy-phenylhydrazone; tBid, truncated form of Bid; β-F1-ATPase, β 
subunit of the mitochondrial H+-ATP synthase; STS, staurosporine; OL, oligomycin. 
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Figure legends 
Figure 1. Oligomycin delays STS-mediated cell death. C9 cells were treated as 
indicated. 1µM STS (St), 6 µM OL (Ol), 20 µM z-VAD.fmk (Z-V) and 20 µM 
aurovertin B (Av) were used. A: Assessment of nuclear DNA fragmentation by 
fluorescence microscopy at 100x magnification and quantification of fragmented nuclei 
at 6 h after initiation of STS treatment. The results shown are the means ± SEM of four 
experiments. *, P<0.05 when compared to STS-treated cells. B: FACS analysis of the 
percentage of hypodiploid cells at various times after STS treatment. Grey bars, OL; 
Closed bars, STS and Open bars, OL+STS. The results shown are the means ± SEM of 
five experiments. *, P<0.05 when compared to STS-treated cells. C: FACS analysis of 
the percentage of hypodiploid cells after treatment with aurovertin B. Grey bars, Av; 
Closed bars, STS and Open bars, Av+STS. The results shown are the means ± SEM of 
six experiments. *, P<0.05 when compared to STS-treated cells. D: Cells were treated 
with OL for the indicated times and the percentage of cells in each of the cell cycle 
phases determined by flow cytometric analysis.  In 12h+W, cells were treated with OL 
for 12h and maintained for additional 3h in the absence of the drug before proceeding to 
the analysis of the cell cycle. (Closed bars, G0/G1; grey bars, S and open bars, G2/M). 
The results shown are the means ± SEM of three experiments. *, P<0.05 when 
compared to non-treated cells. E: Determination of cellular ATP content. The results 
shown are the means ± SEM of four experiments. *, P<0.05 when compared to non-
treated cells. 
Figure 2. Inhibition of other cellular ATPases enhanced STS-mediated cell death. 
C9 cells were treated as indicated. 1µM STS (St), 6 µM OL (Oligo.) and 50 nM 
bafilomycin B1 (Bafilo/Bf) were used. C9 cells incubated with 1 µM acridine orange 
visualized by fluorescence microscopy. Cells are shown at 40x magnification. The 
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results illustrate the lack of effect of OL on other cellular ATPases. The histogram 
shows the FACS analysis of hypodiploid cells. Inhibition of non-mitochondrial 
ATPases by bafilomycin significantly increased STS-triggered cell death. The results 
shown are the means ± SEM of four experiments. *, P<0.05 when compared to STS-
treated cells. 
Figure 3. Changes in cellular mitochondrial morphology after STS treatment are 
not influenced by OL.  Mitochondria-tagged gfp C9 cells were treated as indicated and 
visualized by fluorescence microscopy. 1µM STS (Stauro.), 6 µM OL (Ol.) and 20 µM 
z-VAD.fmk (Z) were used for treatments. A, Typical cellular morphologies are shown 
for each condition at 60x magnification. The plot shows the time-course changes in 
mitochondrial width recorded in OL (pink), STS (blue) and OL+STS (green) treated 
cells. The results shown are the means ± SEM of 100-200 determinations in at least 50 
different cells. B, Different time-frames of the movie (see supporting video 1) illustrate 
the rapid STS-induced changes on the mitochondrial network. Note that within the first 
15 min thread-like mitochondria fission and are disorganized. Afterwards, fragmented 
mitochondria fusion into larger size organelles and move towards the nucleus.  
Figure 4.  The release of cyt c and activation of caspase 3 is delayed in OL-treated 
cells. Mitochondria-tagged gfp C9 cells were treated as indicated with none (Control) or 
1µM STS in the absence (Stauro.) or presence of 6 µM OL (Stauro. + Oligo.). A: FACS 
determination of the mitochondrial membrane potential (∆Ψm) in STS (open bars) and 
STS + OL (closed bars) treated cells. ∆Ψm was also assessed in C9 cells treated for 30 
min with 50 µM of the mitochondrial uncoupler FCCP (Grey bar). The results shown 
are the means ± SEM of four-six experiments. *, P<0.05 when compared to STS-treated 
cells. ‡ and #, P<0.05 when compared to 0h non-treated cells. B and C:  At various 
times after initiation of the STS treatment the cells were analyzed by 
 34
immunofluorescence microscopy using anti-cytochrome c antibody. Nuclear DNA was 
stained with To-Pro. Typical morphologies of the cells at 3h after STS-treatment are 
shown (B) for each condition at 60x magnification. Quantification of the percentage of 
cyt c positive cells (C). The results are the means ± SEM of three experiments. *, 
P<0.05 when compared to STS-treated cells. D: Time course of the effect of OL on the 
activation of caspase 3 activity and inhibition of caspase 3 activation after 1 h pre-
incubation of C9 cells with 20 µM z-Vad.fmk (closed bar). The results shown are the 
means ± SEM of four experiments. * and #, P<0.05 when compared to 3h or 6h STS-
treated cells, respectively.  
Figure 5. The activity of the H+-ATP synthase controls the generation of ROS after 
STS treatment. Liver C9 cells and/or mitochondria-tagged gfp C9 cells were treated as 
indicated. 1µM STS (St), 6 µM OL (Oligo), 2 µM rotenone (Roten) and 10 µM 
pyrrolidine dithiocarbamate (PDTC) were used for the treatments. A: Fluorimetric 
determination of the generated H2O2 at 90 min after initiation of the STS treatment. The 
results shown are the means ± SEM of five experiments. * and ‡, P<0.05 when 
compared to non-treated cells and STS-treated cells, respectively. B, C and D, FACS 
determination of the generated H2O2 in OL-treated (B), FCCP (0-5 µM) uncoupled (C) 
and PDTC-treated (D) cells. The results shown are the means ± SEM of three, seven 
and seven experiments, respectively. * and ‡, P<0.05 when compared to non-treated and 
STS-treated cells, respectively. E, FACS analysis of hypodiploid cells in PDTC treated 
cells. The results shown are the means ± SEM of six experiments. *, P<0.05 when 
compared to STS-treated cells. F:  At various times after initiation of the STS treatment 
mitochondria-tagged gfp C9 cells were analyzed by immunofluorescence microscopy 
and the percentage of cyt c positive cells quantified. The results are the means ± SEM of 
three experiments. *, P<0.05 when compared to STS-treated cells. G: Time course of 
 35
the effect of PDTC on the activation of caspase 3 after STS-treatment. The results 
shown are the means ± SEM of four experiments. *, P<0.05 when compared to STS-
treated cells.  
Figure 6. The activity of the H+-ATP synthase controls oxidative damage of 
cellular proteins. A, C9 cells were treated as previously indicated. Cellular proteins (20 
µg) were derivatizated in the absence (-) or presence (+) of DPNH and processed for the 
identification of protein carbonyls. Protein loading of the samples was verified by 
western blotting with anti-tubulin antibody. Molecular mass markers (97, 66, 45 and 30 
kDa) are indicated to the left. The asterisks to the left of the gel identified the four 
proteins used for the quantification of protein carbonylation in response to the various 
treatments. A representative blot of three different experiments is shown. The results 
shown are the means ± SEM of three experiments. * and # , P<0.05 when compared to 
control and STS-treated cells, respectively. B, Mitochondria-tagged gfp C9 cells were 
treated as indicated. 1µM STS (St) and 6 µM OL (Oligo) were used for the treatments. 
Cellular proteins were fractionated after the indicated treatments on 2D-gels and AIF, 
Endo G and gfp visualized by Western blot. Representative blots of three different 
experiments are shown. Arrowheads denote changes in the pI of the proteins. 
Figure 7. Role of oxidative phosphorylation in STS-triggered cell death in 
hepatoma cells.   AS30D and FAO hepatoma cells were treated as indicated with 1µM 
STS. 6 µM OL was used for treatments. A: Determination of cellular ATP content in 
AS30D cells after 6h treatment with STS. The results shown are the means ± SEM of 
four experiments. B: Fluorimetric determination of the generated H2O2 at 90 min after 
initiation of the STS treatment in AS30D cells. The results shown are the means ± SEM 
of three experiments. C: Determination of cellular ATP content in FAO cells. The 
results shown are the means ± SEM of four experiments. *, P<0.05 when compared to 
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non-treated cells. D: FACS analysis of hypodiploid cells (open bars) and determination 
of caspase 3 activity (closed bars) in FAO cells treated for 6h with STS. 20 µM z-
Vad.fmk was used as indicated. The results are the means ± SEM of three (cell death) 
and four (caspase 3) experiments. * and ‡, P<0.05 when compared to non-treated and 
STS-treated cells, respectively.  E: FACS determination of the generated H2O2 at 30 
min after initiation of the STS treatment in FAO cells. The results shown are the means 
± SEM of three experiments. * and ‡, P<0.05 when compared to non-treated and STS-
treated cells, respectively. F: Proteins from C9, FAO and AS30D cells were 
fractionated by SDS-PAGE and the putative processing of Bid analyzed by Western 
blot after 6h treatment with STS. The cellular expression of Bcl-XL and Bax were also 
analyzed in these cells and expressed relative to the signal of tubulin.  
 
 







SUPPLEMENTARY MATERIAL 
Video 1. STS-induced changes in the cellular mitochondrial network. Images from 
mitochondria-tagged gfp C9 cells incubated with 1µM STS were obtained every 3 min. 
The rapid fission and disorganization of thread-like mitochondria is observed as a very 
early event (~ 10 min) after STS treatment. The migration, nuclear clustering and fusion 
of the fragmented organelles occur at a later stage (~ 60-90 min) of treatment of the 
cells with STS. Images representing individual frames are shown in Fig. 3B. 
